RegentAtlantic Capital’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

RegentAtlantic Capital’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-160,181	Closed	-$12M	–	389
2015 Q3	$12M	Sell	160,181 -10,273	-6%	-$767K	1.15%	18
2015 Q2	$12.8M	Sell	170,454 -4,000	-2%	-$214K	1.14%	20
2015 Q1	$8.75M	Sell	174,454 -2,000	-1%	-$83.9K	0.77%	31
2014 Q4	$6.12M	Hold	176,454	–	–	0.52%	51
2014 Q3	$5.78M	Hold	176,454	–	–	0.54%	49
2014 Q2	$6.77M	Hold	176,454	–	–	0.63%	40
2014 Q1	$7.02M	Sell	176,454 -17,000	-9%	-$760K	0.68%	39
2013 Q4	$7.23M	Buy	+193,454	New	+$8.02M	0.7%	38

RegentAtlantic Capital's KYTH Position: Q4 2015 in Review

RegentAtlantic Capital sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 160,181 shares — an estimated $12M sold.

RegentAtlantic Capital first reported a position in KYTH in Q4 2013 and held it in 8 quarters. The position peaked at $12.8M in Q2 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

RegentAtlantic Capital reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
RegentAtlantic Capital sold 160,181 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $12M.
RegentAtlantic Capital first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q4 2013 and held it in 8 quarters.
RegentAtlantic Capital's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $12.8M in Q2 2015.
0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on RegentAtlantic Capital's 13F filing for Q4 2015, filed 26 Jan 2016.